Shares of Cigna Corporation (NYSE:CI) recorded 0.93% gain during trading session on March 14th, 2019. The script traded as low as $168.31 and last traded at $169.56. 3.76 million shares changed exchanged hands during trading, a drop of -17.35% from the 30-day average session volume of 3.20M shares. The firm had previously closed at $168.00. The company has $381.62M outstanding shares, a price-to-earnings ratio of 15.89, price-to-earnings-growth ratio of 1.33and a beta of 0.74. The company has a RSI of 38.70, ATR of 4.58 and a volatility of 1.94% this week. CI has a 52 week low price of $162.42 and a 52 week high price of $226.60.
Investors have identified the tech company Cigna Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around 64.71B, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cigna Corporation (CI) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For CI, the company has in raw cash 3.86 billion on their books with 57.6 billion currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 4.56 billion total, with 153.23 billion as their total liabilities. This figure have given the company a good sense of viability under numerous contexts.
CI were able to record 3.24 billion as free cash flow during the recently reported quarter of the year, this saw their quarterly net cash flow reduce by 883 million. In cash movements, the company had a total of 3.77 billion as operating cash flow.
Potential earnings growth for Cigna Corporation (CI)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the third quarter of the year, Cigna Corporation recorded a total of 14.34 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 0.27% coming in sequential stages and their sales for the third quarter increasing by 0.20%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 13.53 billion trying to sell their products during the last quarter, with the result yielding a gross income of 228 million. This allows shareholders to hold on to 381.62M with the revenue now reading 0 cents per share. This is a figure that is close to analyst’s prediction for their fourth quarter (3.88 cents a share).
Is the stock of CI attractive?
Having a look at the company’s valuation, the company is expected to record 18.51 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CI sounds very interesting.
In related news, Director ZOLLARS WILLIAM D sold 201 shares of the company’s stock in a transaction that recorded on December 14th, 2019. The sale was performed at an average price of 210.84, for a total value of 42,379. As the sale deal closes, the President, US Markets ZOLLARS WILLIAM D now sold 2,825 shares of the company’s stock, valued at 605,253. Also, Pres., International Markets Sadler Jason D sold 21,189 shares of the company’s stock in a deal that was recorded on November 2nd, 2019. The shares were sold at an average price of 212.99 per share, with a total market value of 25,339. Following this completion of acquisition, the Director now holds 238 shares of the company’s stock, valued at 46,101. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.30%.
7 out of 23 analysts covering the stock have rated it a Buy, while 4 have maintained a Hold recommendation on Cigna Corporation stock. 0 analysts has assigned a Sell rating on the CI stock. The 12-month mean consensus price target for the company’s shares has been set at $240.19.